Insider · CIK 0001622052
Steven R. King
Files at JAGX (Jaguar Health, Inc.). First filing -, latest -.
Steven R. King files SEC Form 4 as officer at JAGX (Jaguar Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven R. King has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Common Stock | +11,740 | $0.00 | $0 | 11,885 | Jan 21, 2026 |
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,740 | $0.00 | $0 | 11,740 | Jan 21, 2026 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | DDisposition to issuer Convertible Promissory Notederivative | -3,600 | $20,000.00 | $72M | 0 | Jun 26, 2025 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Convertible Promissory Notederivative | +3,785 | $20.00 | $76k | 3,785 | Jun 26, 2025 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Warrant to Purchase Common Stockderivative | +7,304 | - | - | 3,600 | Jun 26, 2025 |
| May 17, 2025 | JAGX Jaguar Health, Inc. | MOption exercise Common Stock | +1 | - | - | 145 | May 20, 2025 |
| May 17, 2025 | JAGX Jaguar Health, Inc. | MOption exercise Restricted stock unitsderivative | -1 | $0.00 | $0 | 0 | May 20, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Convertible Promissory Notederivative | +3,600 | $20,000.00 | $72M | 3,600 | Apr 2, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivative | +3,600 | - | - | 3,600 | Apr 2, 2025 |
Questions about Steven R. King
Answered from the filings on this page, as of the latest one.
Is Steven R. King buying or selling?
Steven R. King has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven R. King's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven R. King has 0.
Where does Steven R. King file Form 4?
Steven R. King has filed Form 4 at JAGX (Jaguar Health, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.